Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/09/2012US8283342 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
10/09/2012US8283333 Lipid formulations for nucleic acid delivery
10/09/2012US8283135 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
10/09/2012US8282990 Method for preparing a biodegradable polymer microsphere containing a glucose-regulating peptide
10/09/2012US8282967 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
10/09/2012US8282962 water-dispersible particulate composition comprising by weight of dry matter at least 10% of xanthan gum and not more than 60% of starch, said composition being characterised in that the xanthan gum present in the composition can be dispersed completely within 2 minutes in distilled water of 25 degrees
10/09/2012US8282961 Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule
10/09/2012US8282960 Ion binding compositions
10/09/2012US8282959 Branched end reactants and polymeric hydrogel tissue adhesives therefrom
10/09/2012US8282958 Coating method
10/09/2012US8282957 Coated particles containing pharmaceutically active agents
10/09/2012US8282956 Coated tablet
10/09/2012US8282955 Drying, evaporating and desolventizing to form the powder; oral administering
10/09/2012US8282947 Low viscosity, unstable water-in-silicone emulsion cosmetic compositions and methods of use thereof
10/09/2012US8282944 Metal complexes incorporated within biodegradable nanoparticles and their use
10/09/2012US8282938 Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain
10/09/2012US8282915 Transgenic algae for delivering antigens to an animal
10/09/2012US8282913 Ion binding polymers and uses thereof
10/09/2012US8282909 Pharmaceutical composition for topical application of poorly soluble compounds
10/09/2012US8282627 Methods and apparatus for translating a continuous-delivery delivery profile into a plurality of periodic bolus deliveries
10/09/2012US8282626 Portable infusion pump and media player
10/09/2012US8282625 Implantable medical device with time for therapeutic output replenishment determination and method therefore
10/09/2012US8282607 Sleeve and micro-encapsulated topical analgesic for pain relief
10/09/2012US8281958 Method of producing foamed cleanser with suspended particles therein and a dispenser therefore
10/09/2012CA2747845C Compositions and methods for dermally treating pain
10/09/2012CA2576689C Pharmaceutical compositions for controlled release delivery of biologically active compounds
10/09/2012CA2569542C A delivery system
10/09/2012CA2560432C Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
10/09/2012CA2544572C Method of coating granules containing mesalazine
10/09/2012CA2544139C Suspension of loteprednol etabonate and tobramycin for topical ophthalmic use
10/09/2012CA2533845C Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
10/09/2012CA2531097C Process for preparing formulations of lipid-regulating drugs
10/09/2012CA2522191C Delivery vehicle for silver ions
10/09/2012CA2520475C Tumor-targeting drug-loaded particles
10/09/2012CA2510320C Coated particles for sustained-release pharmaceutical administration
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2451135C Method of manufacturing tablet
10/09/2012CA2451040C Gum resin for topical administration of pharmacologically active agents
10/09/2012CA2448622C Proliposomal drug delivery system
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/04/2012WO2012135808A2 Intraoperative and blood-derived adhesives
10/04/2012WO2012135805A2 Delivery and formulation of engineered nucleic acids
10/04/2012WO2012135743A2 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
10/04/2012WO2012135619A2 Intranasal benzodiazepine pharmaceutical compositions
10/04/2012WO2012135617A1 Short -acting dihydropyridines (clevidipine) for use in reducing stroke damage
10/04/2012WO2012135592A2 Theranostic imaging agents and methods of use
10/04/2012WO2012135575A2 Compositions and methods for introduction of macromolecules into cells
10/04/2012WO2012135562A2 Polymer conjugates targeting cells and methods related thereto
10/04/2012WO2012135561A1 Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol
10/04/2012WO2012135559A1 Menthol liquids composition
10/04/2012WO2012135536A1 Nasal formulations of benzodiazepine
10/04/2012WO2012135337A2 Topical skin care formulations comprising plant extracts
10/04/2012WO2012135129A1 Gel carrier for releasing active ingredients
10/04/2012WO2012135010A2 Osmotic mediated release synthetic nanocarriers
10/04/2012WO2012134590A2 Calcium supplement
10/04/2012WO2012133997A1 Polysorbitol-based osmotically active transporter and gene therapy using same
10/04/2012WO2012133960A1 Inhibitor for dipeptidyl peptidase iv
10/04/2012WO2012133918A1 Solid preparation
10/04/2012WO2012133884A1 Pharmaceutical composition containing block copolymer comprising boric acid compound
10/04/2012WO2012133817A1 Vesicle composition
10/04/2012WO2012133648A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
10/04/2012WO2012133554A1 Fat emulsion containing prostaglandin
10/04/2012WO2012133492A1 Ointment with excellent formulation stability
10/04/2012WO2012133409A1 Externally used drug kit
10/04/2012WO2012133408A1 Film-shaped externally used drug composition
10/04/2012WO2012133407A1 Film-shaped externally used drug composition
10/04/2012WO2012133246A1 Carotenoid-containing composition and method for producing same
10/04/2012WO2012133121A1 Long-lasting controlled-release liposome composition and method for producing same
10/04/2012WO2012132141A1 Composition for delivering drug into cell and method therefor
10/04/2012WO2012131722A1 Controlled release composition of betahistine
10/04/2012WO2012131690A1 Drug delivery form as a bilayer tablet
10/04/2012WO2012131678A1 Sustained-release injectable formulation
10/04/2012WO2012131669A1 Film-forming composition for a ph-dependant sustained release of the active agent
10/04/2012WO2012131493A1 Compositions for the treatment of neurologic disorders
10/04/2012WO2012131476A1 Composition and method for controlling release of active ingredient
10/04/2012WO2012131348A1 Salicylic acid topical formulation
10/04/2012WO2012131347A1 Usnic acid topical formulation
10/04/2012WO2012131238A1 Composition containing a cellulose, a vegetable oil and a volatile solvent, and use thereof as a dressing
10/04/2012WO2012131237A1 Film-forming composition containing a sun filter, and use thereof for the treatment of scars
10/04/2012WO2012131106A1 Biodegradable compositions suitable for controlled release
10/04/2012WO2012131104A2 Biodegradable compositions suitable for controlled release
10/04/2012WO2012131018A1 Nanoparticles loaded with chemotherapeutic antitumoral drug
10/04/2012WO2012131005A1 Pharmaceutical composition of sitagliptin
10/04/2012WO2012130819A1 Otamixaban formulations with improved stability
10/04/2012WO2012130567A1 Method for encapsulated therapeutic products and uses thereof
10/04/2012WO2012130336A1 Delivery of large molecular weight biologically active substances
10/04/2012WO2012130193A1 Non-covalent soluble complexes of teriparatide with polysaccharides and a dosage form of teriparatide for oral administration
10/04/2012WO2012130141A1 Method and composition for enhancing target cells uptake of therapeutic agents
10/04/2012WO2012130117A1 Mask structure for use in decreasing transmission of human pathogens
10/04/2012WO2012130116A1 Compound preparation treating alzheimer's disease and preparation method thereof
10/04/2012WO2012129949A1 Use of traditional chinese medicine composition in preparation of anti-enterovirus 71 drug
10/04/2012WO2012129859A1 Polyamine compounds and preparative mentods and uses thereof
10/04/2012WO2012129765A1 Method for preparing stable-type vitamin a microcapsules continuously
10/04/2012WO2012129759A1 Oral dosage formulations containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
10/04/2012WO2012129671A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan
10/04/2012WO2012104641A3 Pharmaceutical formulation
10/04/2012WO2012101653A3 Modified release pharmaceutical compositions memantine
10/04/2012WO2012094541A3 Acoustically responsive particles with decreased cavitation threshold
1 ... 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 ... 2991